Morgan Lewis

Life Sciences Transactions Related News

For More Information

Read the brochure

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Related Publications

06/19/08 From Europe and Japan to the U.S.: Build or Buy?, presented at the 2008 BIO International Convention, San Diego, CA
05/24/05 Pharmaceutical Industry Mergers: Anticipating Antitrust Issues and Surviving the Investigation, presented at the American Conference Institute In-House Counsel Forum on Pharmaceutical Antitrust, Washington, D.C.
View all publications

Related News

09/16/14 Morgan Lewis Tops BioPharm Insight Second-Quarter League Tables
Morgan Lewis is pleased to announce that its Life Sciences and Healthcare practice has again placed among the top firms in BioPharm Insight ’s quarterly league tables.
04/11/13 Morgan Lewis Advises MEI Pharma on $15.2 Million Registered Offering of Common Stock
Morgan Lewis served as legal adviser to MEI Pharma, Inc. on registered offering of common stock.
10/29/10 Morgan Lewis Advises Safeguard Scientifics on $587 Million Sale of Clarient to GE Healthcare
In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.
View all news

Honors

BioPharm Insight 2013 Q3

  • Ranked 1st – Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific – Based on Value
  • Ranked 2nd – Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific – Based on Volume
  • Ranked 3rd – Legal Advisors to Biotech and Pharma Licensing Agreements: Europe – Based on Value
  • Ranked 8th – Legal Advisors to Biotech and Pharma Licensing Agreements: Europe – Based on Volume
  • Ranked 7th – Global League Table of Legal Advisors to Biotech and Pharma Licensing Agreements – Based on Value
  • Ranked 9th – Global League Table of Legal Advisors to Biotech and Pharma Licensing Agreements – Based on Volume
  • Ranked 10th – Legal Advisors to Biotech and Pharma Licensing Agreements: North America – Based on Value
  • Ranked 10th – Legal Advisors to Biotech and Pharma Licensing Agreements: North America – Based on Volume
6 news articles found
page 1 of 1
Sep 16, 2014 - Morgan Lewis Tops BioPharm Insight Second-Quarter League Tables

Morgan Lewis is pleased to announce that its Life Sciences and Healthcare practice has again placed among the top firms in BioPharm Insight’s quarterly league tables.

Apr 11, 2013 - Morgan Lewis Advises MEI Pharma on $15.2 Million Registered Offering of Common Stock

Morgan Lewis served as legal adviser to MEI Pharma, Inc. on registered offering of common stock.

Oct 29, 2010 - Morgan Lewis Advises Safeguard Scientifics on $587 Million Sale of Clarient to GE Healthcare

In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.

Oct 28, 2010 - Morgan Lewis Advises BMP Sunstone on Acquisition by Sanofi-Aventis

BMP Sunstone and sanofi-aventis announced that they have entered into a definitive agreement where sanofi-aventis will acquire all outstanding shares of BMP Sunstone at $10 per share, or approximately $520.6 million.

Sep 24, 2009 - Morgan Lewis Advises LEO Pharma on $1 Billion Acquisition

Morgan Lewis represented LEO Pharma in the $1 billion acquisition of exclusive product licensing rights and inventories from LEO Pharma by Warner Chilcott plc.

Sep 14, 2007 - 141 Morgan Lewis Lawyers Receive The Best Lawyers in America (2008)

141 Morgan Lewis lawyers have been recognized in The Best Lawyers in America 2008.

page 1 of 1